NIH study reveals how melanoma spreads
Identifying HIF1α-regulated genes and their expression patterns reveals potential biomarkers that predict melanoma metastasis and offer new therapeutic targets.
This study identified 40 new genes regulated by HIF1α in melanoma, and 10 genes associated with the time to metastasis, indicating potential targets for personalized therapy and predictive biomarkers of disease progression.
Understanding the genes that drive melanoma metastasis could improve prognostic accuracy and inform the development of targeted and immuno‑therapeutic strategies.
Evidence level: Állatkísérletes. Állatmodellben vizsgálták.
Related signals
- Beyond the Five-Year Milestone: Long‑term Survivorship of Melanoma Patients Treated Off‑Trial with anti‑PD‑1
- Uveal Melanoma – Trials in Disease – Overview of Information and Clinical Research
- A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma
- Melanoma Research
- The Clinical Trial Landscape for Melanoma Therapies